20220313 China News
Source: | Author:eacham | Published time: 2022-03-13 | 968 Views | Share:



01

China Meheco Group Co Ltd signed an agreement with Pfizer Inc to supply the latter's COVID-19 treatment Paxlovid in the Chinese mainland in 2022, the company said Wednesday. The move marks China Meheco becoming the domestic agent of the new COVID-19 pill. Pfizer also confirmed the news on its official website and WeChat account.

 

02

The Chinese mainland on Wednesday reported 402 locally transmitted COVID-19 cases, up from 233 on Tuesday, the National Health Commission said Thursday. Of the new local infections, 165 were reported in Jilin, 66 in Shandong and Gansu respectively, 21 in Shaanxi, 19 in Tianjin, 17 in Guangdong, and 13 in Jiangsu. The rest of the cases were reported in other nine provincial-level regions, the commission said in its daily report.

 

03

More tourism and culture venues as well as hospitals in Shanghai were shut down on Thursday after the city reported five new locally transmitted COVID-19 cases with mild symptoms and 21 local asymptomatic cases. Apart from an asymptomatic case who tested positive during screening, all the other cases returned positive tests after being centrally quarantined as close contacts of previous cases, Wu Jinglei, head of the Shanghai Health Commission, told a press briefing.

 

04

Big enterprises and logistics, catering, and entertainment industries in China posted larger demand for talents this spring, according to a report released by Zhilian Recruitment's research institute on Monday.

 

05

Seven universities from the Chinese mainland have secured positions among the top 10 in the Times Higher Education's Emerging Economies University Rankings 2022 for the fifth straight year. The mainland is not only home to all of the top five positions in the ranking, but also 10 of the top 15.

 

06

China's full-year inflation is likely to stay generally under control in 2022 with the government's effective measures to ensure stable supplies and prices of bulk commodities, experts said.


07

Chinese manufacturer CRRC Zhuzhou Locomotive Co Ltd said Thursday that tests have been completed for its next generation of commercial maglev train. The train, with a designed speed of 200 km per hour, has achieved multiple tech breakthroughs such as unmanned driving and non-contact power supply, said Zhang Wenyue, deputy head of CRRC Zhuzhou Locomotive's maglev research institute.




Author: Producer Emilio Mendez

Speaker: Caroline Parraguez

Edition: EAcham


Guangzhou Office:
Suite 1816-1819, Guangzhou International Sourcing Center, No. 8 Pazhou Avenue East ,Haizhu District, Guangzhou, Guangdong Province.
Tel：+86-20-89059525

E-mail：gz@eacham.org

Shanghai Office:

Global Chambers Zone 

No.624C of Office Building B, National Convention and Exhibition Center(Shanghai)

Tel：+86-13917039347

E-mail：shanghai@eacham.org

Contact us
Beijing Office:

Room 607, No,1 East International Building, No,1 Ciyunsi, Chaoyang District, Beijing.

Tel：+86-10-64952381

Fax：+86-10-64958922
E-mail：info@eacham.org